Trial intelligence / Profile preview

Botox vs saline injection into puborectalis muscle in pelvic floor dyssynergia

2005-001378-29Phase 4Completed

Sponsor
Bradford Teaching Hospitals NHS Foundation Trust
Start
Apr 2005
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of botulinum toxin type A in Anismus (DD) and Pelvic floor dyssynergia (PFD) (2 arms), sponsored by Bradford Teaching Hospitals NHS Foundation Trust. Primary endpoint: Improved defecation. Started Apr 2005; status: completed.

02

Drugs

botulinum toxin type A
03

Conditions

Anismus (DD)Pelvic floor dyssynergia (PFD)

Beyond the preview

Go deeper on 2005-001378-29.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-001378-29.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call